3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
10
Terminated
6
Recruiting
6
Unknown
5
Active not recruiting
2
Withdrawn
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
1
Interventions
Paclitaxel
24
Carboplatin
18
Bevacizumab
14
Cisplatin
12
pembrolizumab
7
fluzoparib
7
Drug Therapy
7
Radiotherapy
6
camrelizumab
5
apatinib
5
Topotecan
5
Magnetic Resonance Spectroscopy
5
Injections
5
liposomal doxorubicin
4
lenvatinib
4
famitinib
4
Tirzepatide
4
Specimen Handling
4
Platinum
4
Observation
4
Gemcitabine
4
Brachytherapy
4
toripalimab
3
olaparib
3
dostarlimab
3
anlotinib
3
Watchful Waiting
3
Therapeutics
3
Surveys and Questionnaires
3
Neoadjuvant Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
1-dodecylpyridoxal
×
Gynecologic
×
Clear all
NCT07564141
2026-06-03
RAINFOLâ„¢-07
Genmab
Phase 3
Not yet recruiting
688 enrolled